Opendata, web and dolomites


Final development, clinical validation and launch preparation of NL01, an innovative health ingredient for supplements, food products and foods for special medical purposes

Total Cost €


EC-Contrib. €






 NUTRI-NEED project word cloud

Explore the words cloud of the NUTRI-NEED project. It provides you a very rough idea of what is the project "NUTRI-NEED" about.

immune    representing    medium    purposes    danone    company    food    2026    fresenius    industrial    generate    isolated    revenues    live    preclinical    register    data    benefits    demand    crop    population    eacute    licensing    desired    market    components    proven    works    leaders    resistance    ec    proprietary    status    deals    huge    launch    consumers    game    regulatory    patients    healthy    approved    infections    adults    million    claim    46x    ingredients    commercial    gt    companies    dietary    friesland    perform    life    250    campina    supports    plant    functional    licence    cumulative    dsm    first    clinical    function    ingredient    nestl    grant    complete    risk    young    small    nl01    changer    abbott    projected    supplements    foods    track    kg    supporting    claims    dynamic    health    elderly    registration    containing    obtain    inclusion    efsa    people    humans    nutrileads    advice    isolation    clinically    entry    industry    115    medical    safety    shown    infection   

Project "NUTRI-NEED" data sheet

The following table provides information about the project.


Organization address
address: BRONLAND 12 N
postcode: 6708 WH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website
 Total cost 3˙567˙000 €
 EC max contribution 2˙496˙900 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUTRILEADS BV NL (WAGENINGEN) coordinator 2˙496˙900.00


 Project objective

People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increases resistance to infections’.

NutriLeads is a dynamic Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits. With its proprietary lead ingredient NL01, having completed preclinical data and proven safety in humans, NutriLeads is on track to become the first company to launch an ingredient with an approved health claim for supporting immune function and increasing infection resistance. Targeted end-users of NL01 containing food products (dietary supplements, medical- and functional foods) are young adults, adults, elderly and patients, aiming to support their health and immune status.

Nutrileads selected a common crop from which NL01 can be isolated, a game-changer for its commercial success,and developed the isolation process for NL01 up to small scale industrial plant production. In this project, Nutrileads will perform medium scale-up of the production process to 250 kg. Nutrileads will complete the data package for NL01 with a clinical study in a relevant population with increased infection risk to support the health claims on NL01, register NL01 as ‘Novel Food’ and obtain European Food Safety Authority (EFSA) regulatory advice on registration as ‘Food for Specific Medical Purposes’.

NutriLeads will generate revenues from out-licensing NL01 to large companies in the food industry. Market leaders Abbott, Nestlé, Friesland Campina, Danone, Fresenius regularly in-licence components for inclusion in their products; Nestlé and DSM have already shown interest in Nutrileads’ products. Nutrileads works towards market entry and first deals during or directly after this project with a projected best-case cumulative revenues of €115 million in 2026, representing >46x the EC grant.


List of deliverables.
NL01 brand & logo Websites, patent fillings, videos etc. 2019-08-01 13:00:52

Take a look to the deliverables list in detail:  detailed list of NUTRI-NEED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUTRI-NEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUTRI-NEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  


Automated, Fast Generation of High-Performance Instruction Set Simulators for Microprocessors

Read More  

Cancersensing (2019)

A multi-cancer screening platform for fast and accurate early stage cancer detection from urine samples

Read More